investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Prostate Cancer Imaging
Peter Choyke
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Amato J Giaccia
Tumor Hypoxia: Molecular Studies and Clinical Exploitation
Prostate
Radiation Oncology
Marja T Nevalainen
Novel Strategy to Sensitize Prostate Cancer Cells to Radiation
Prostate
Radiation Oncology
Philip Tofilon
Radiation-induced translational control of gene expression
Prostate
Radiation Oncology
Michael Bustin
Biological Functions of Chromosomal Proteins
Prostate
Radiation Oncology
Li Xin
The Notch Signaling in Prostate Homeostasis and Carcinogenesis
Prostate
Donna L. Berry
Personal Patient Profile-Prostate: Testing and Implementation in Health Networks
Prostate
Radiation Oncology
Surgery / Surgical oncology
David S Rickman
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis
Prostate
Pathology
Stephen N Thibodeau
Prostate Cancer Susceptibility: The ICPCG Study
Prostate
Pathology
Eliezer M Van Allen
Resistance to Emerging Androgen Deprivation Therapies in Prostate Cancer
Prostate